The 2013 Rocky Mountain Life Science Investor and Partnering Conference keynote breakfast will include Kyle Lefkoff, founder and General Partner of Boulder Ventures, leading a conversation with the CEOs of Colorado's two premier publicly-traded pharmaceutical companies – Patrick Mahaffy, Founder and CEO of Clovis Oncology and Ron Squarer, CEO of Array BioPharma. The announcement is made by April Giles, President and CEO of the Colorado BioScience Association (CBSA) who says the regional conference will also feature a keynote luncheon presentation by Jeff Calcagno, M.D., Principal, Venture Investments, Johnson and Johnson Development Corporation.
Lefkoff, one of the region’s leading venture capitalists and a member of the conference steering committee since 2009, says: “Clovis Oncology and Array BioPharma have been incredibly successful reaching both funding and developmental milestones. This is a great opportunity to hear first-hand from their leadership how they have achieved this success and what they look forward to in the future.”
Link to the Business Wire release
Link to the PitchEngine Social Media Release
No comments:
Post a Comment